Advertisement

Topics

Pharmacovigilance as a Source of Product Differentiation

09:00 EDT 11 Aug 2017 | PharmPro

Pharmacovigilance as a discipline should not be confined to regulatory compliance. Leading life sciences companies are using it to shape a number of strategic priorities, from M&A decisions to product innovation.
Contributed Author: 
Adam Sherlock, CEO, ProductLife Group
Topics: 

Original Article: Pharmacovigilance as a Source of Product Differentiation

NEXT ARTICLE

More From BioPortfolio on "Pharmacovigilance as a Source of Product Differentiation"

Quick Search
Advertisement
 

Relevant Topic

Clinical Research Organization
Contract Research Organization (CRO) provide research services outsourced on a contract basis to the pharmaceutical, biotechnology, healthcare and medical device industries: biopharmaceutical development biologic assay development commercial...